Lantheus Holdings, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Bedford, MA
LNTH chart
What traders are saying about $LNTH
Latest postsLantheus Holdings, Inc. news
- PharmaLogic Acquires Lantheus CDMO Unit, Expands U.S. Radiopharma Capacity
Contract Pharma ·
- Lantheus (NASDAQ:LNTH): strongest Q3 results from the healthcare equipment and supplies group
StockStory ·
- PharmaLogic: Lantheus CDMO Acquisition Expands Radiopharmaceutical Manufacturing Capacity In New Jersey
Pulse 2.0 ·
- Lantheus to Sell CDMO Business to PharmaLogic
TipRanks ·
- PharmaLogic to acquire Lantheus CDMO business and manufacturing facility
European Pharmaceutical Review ·
- A New Jersey manufacturing plant is part of Lantheus (LNTH)'s planned business sale.
Stock Titan ·
- PharmaLogic Signs Lantheus CDMO Deal With Long-Term Supply Agreement
Securities.io ·
- PharmaLogic to acquire Lantheus CDMO unit in New Jersey
Investing.com ·
- PharmaLogic to Acquire Lantheus' CDMO Unit and Springfield Manufacturing Site, Enhancing Radiopharmaceutical Capabilities
Kalkine Media ·
- PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility
Yahoo Finance ·
- Curium’s Lantheus acquisition draws US FTC second request
MLex ·
- Lantheus Holdings Releases Q3 2026 Financial Results
AlphaStreet ·
Lantheus Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.54B | $1.53B | $1.30B | $935.1M |
| Net income | $233.6M | $312.4M | $326.7M | $28.1M |
| Diluted EPS | $3.41 | $4.36 | $4.65 | $0.40 |
| Total assets (year end) | $2.23B | $1.98B | $1.65B | $1.32B |
| Cash and equivalents (year end) | $359.1M | $912.8M | $713.7M | $415.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lantheus Holdings, Inc.
- Ticker
- LNTH (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Bedford, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1521036
- Former names
- Lantheus MI Holdings, Inc.
Frequently asked questions
What exchange is Lantheus Holdings, Inc. listed on?
Lantheus Holdings, Inc. trades on the Nasdaq under the ticker symbol LNTH.
What industry is Lantheus Holdings, Inc. in?
Lantheus Holdings, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Lantheus Holdings, Inc. headquartered?
Lantheus Holdings, Inc.'s business address on file with the SEC is in Bedford, MA.
When does Lantheus Holdings, Inc.'s fiscal year end?
Lantheus Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Lantheus Holdings, Inc. report?
Lantheus Holdings, Inc. reported $1.54B in revenue for calendar year 2025, according to its SEC filings.